163 results
Page 4 of 9
8-K
EX-99.1
jxfw9dev
5 Nov 20
FibroGen Reports THIRD Quarter 2020 Financial Results
4:05pm
8-K
EX-99.1
t3b6jm
6 Aug 20
FibroGen Reports SECOND Quarter 2020 Financial Results
4:10pm
8-K
EX-99.1
565p53
6 Aug 20
FibroGen Announces New Appointments to its Board of Directors
4:06pm
8-K
EX-99.1
74ta2bhp 0ss
7 May 20
FibroGen Reports First Quarter 2020 Financial Results
4:09pm
8-K
EX-99.1
iuwimwcne6mfilrxq1u
24 Mar 20
Master Supply Agreement
5:24pm
8-K
EX-99.1
cq2gzd4 stf3ux5r
2 Mar 20
FibroGen Reports Fourth Quarter and Full Year 2019 Financial Results
4:06pm
8-K
viiq3v 0lyx1f0l
11 Feb 20
FibroGen Announces U.S. FDA Acceptance of New Drug Application for Roxadustat for the Treatment of Anemia of Chronic Kidney Disease
5:16pm
8-K
EX-99.1
3agtff9v
11 Feb 20
FibroGen Announces U.S. FDA Acceptance of New Drug Application for Roxadustat for the Treatment of Anemia of Chronic Kidney Disease
5:16pm
8-K
yllu2rr8q5vs5s1nv4cz
30 Jan 20
Astellas Submits Supplemental New Drug Application for Approval of
4:40pm
8-K
EX-99.1
gzq2sho
30 Jan 20
Astellas Submits Supplemental New Drug Application for Approval of
4:40pm
8-K
EX-99.1
7hld541vaywos
13 Jan 20
Regulation FD Disclosure
9:01am
8-K
EX-99.1
o73gb 86x
6 Jan 20
Fibrogen Names Enrique Conterno As Chief Executive Officer
5:23pm
8-K
kzotxiv7enw6syyn2dvt
23 Dec 19
Fibrogen Submits New Drug Application to the U.S. Fda for Roxadustat In Patients with Anemia of Chronic Kidney Disease
9:06am
8-K
EX-99.1
4zxhnqj9q
23 Dec 19
Fibrogen Submits New Drug Application to the U.S. Fda for Roxadustat In Patients with Anemia of Chronic Kidney Disease
9:06am